Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	176.03B
Revenue (ttm)	258.70B
Net Income (ttm)	16.41B
Shares Out	15.27M
EPS (ttm)	1,074.45
PE Ratio	10.73
Forward PE	10.62
Dividend	300.00 (2.65%)
Ex-Dividend Date	Dec 27, 2024

Volume	30,741
Average Volume	57,883
Open	11,490
Previous Close	11,340
Day's Range	11,330 - 11,540
52-Week Range	10,050 - 13,530
Beta	0.23
RSI	63.59
Earnings Date	Nov 13, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 409
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.